Pancreatitis During Drug Treatment: a Comparative Evaluation of Three Algorithms in Assessing the Causal Role of Drugs
Main Article Content
Abstract
Background. None of the methods proposed for assessing the possible role of a drug in causing adverse events (AEs) has been accepted as the gold standard because of differences in the criteria used and in the weighing of each criterion. Accordingly, each AE has certain characteristics that differ from the others' such as background incidence, clinical features, etiologies, prognosis, etc. We felt that each method should be appropriate for use in evaluating each major type of AEs. Aim. We wanted to compare three widely used causality algorthms (Naranjo's, Karch and Lasagna's, and the French Imputability system) and to find out which of them is more appriate for assessing the causal role of a drug in cases of acute pancreatitis. Materials and Methods. 100 consecutive cases of pancreatitis in Jansen's AE darbase were assessed using the three algorthms; a Global estimate made by trained experts was used as a reference. The outcomes from the three algorthms were statistically compared using Wilcoxon's matched-pairs Signed Rank Test, Spearman's Rank Correlation Coefficient Test P-values of less than 0.05 were considered significant. Results. We found significant differences and low correlation between each pair of algorithms (r=0.27-0.59, p < 0.05). The highest correlation was obtained from the comparison between the actual scores on Naranjo's algorithm and the Global estimate and the poorest correlation was obtained from the comparison between the French system and the latter. The results from Karch and Lasagna's algorithm were bound to be unrelated or conditional. Naranjo's algorithm yielded overall higher values than the Global estimate (1-level higher) suggesting a non-appropnate grouping of results by this method. Conclusion. Regarding the usefulness of the algorithms, it is conceivable Naranjo's algorithm is the best method in assessing pancreatitis cases given that the grouping of the scores into four qualitative categories are more revised.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Strom BL. Pharmacoepidemiology 2. New York: Churchill Livingstone, 1994.
Michel D, Knodel L. Comparison of three algorithms used to evaluate adverse drug reactions. Am J Hosp Pham 1986;43:1709-14.
Pere JC. Computerized comparison of six adverse drug reaction assessment procedures. Clin Pharmacol Ther 1986;40:451-9.
Naranjo CA, BustoU, Sellers EM,etal. A method for esti mating the probability of adverse drug reaction. Clin Pharmacol Ther 1981;30:239-45.
Karch FE, LasagnalL. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977;21:247-54.
Begaud B, Evreux JC, Jouglard J, Lagier G. Unexpected or toxic drug reaction assessmen (imputation). Actualization of the method used in France. Therapie1985;40:115-8.
Kirlwood BR Essential ofmedicalstatistics.London: Blackwell Scientific Publications; 1996.
Trapnell JE, Duncan EHL. Patterns of incidence in acute pancreatitis. Br Med J 1975;2:179-83.
Corfield AP, Cooper MJ, Williamson RCN.Acute pancreatitis: a lethal disease of increasing incidence. Gut 1985;26:724-9.
Gambill E. Etiology and mechanisms of pancreatitis. Pancreatitis 1973;50-82.
Geokas MC. Ethanol and the pancreas. Med Clin North Am 198 4;68:57-75.
Niederau C, Luthen R. Alkohol und pankreaserkrankungen. Z Gastroenterologie (Suppl 3)1988;2:60-74.
Moreau JA, Zinsmeister AR, Melton LJ, et al. Gallstone pancreatitis and the effect of cholecystectomy: a populationbased cohort study. Mayo Clin Proc 1988; 63:466-73.
Steinberg WM. Acute pancreatitis-never leave a stone unturned. New Engl J Med 1992;326:635-7.
de Lalla F,Pellizzer G, Gradoni L, et al. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis. Clin Infect Dis 1993;16:730-1.
Marbet UA. Gallstone-associated acute pancreatitis: a field for endoscopic therapy. Dig Dis Sci 1992;10: 318-25.
Worning H. Etiologic aspects of chronic pancreatitis. Int J Pancreatol 1989;5:1-9.
Sibert JR. A British family with hereditary pancreatitis. Gut 1975;16:81-8.
Lashner BA, Kirsner JB, Hanauer SB. Acute pancreatitis associated with high concentration lipid emulsion duringtotal parenteral nutrition therapy for Crohn's disease. Gastroenterology 1986;9:1039-41.
Bess MA, Edis AJ, Van Heerden JA. Hyperparathyroidism and pancreatitis. Chance or a causal association? JAMA 1980;24:246-7.
Izsak EM, Shike M, Roulet M, et al. Pancreatitis in association with hypercalcemia in patients receiving total parenteral nutrition. Gastroenterol 1980;7:555-8
Tromm A, Huppe D, Micklefield GH, et al. Acute pancreatitis complicating Crohn's disease: mere coincidence or causality? Gut 1992;33:1289-91.
Meltzer SJ, Korelitz BI. Pancreatitis and duodenopancreatic reflux in Crohn's disease. J Clin Gastroenterol 198;10: 555-8.
Zuger A, Wolf B,El-Sadr W,et al. Pentamidine-associated fatal acute pancreatitis. JAMA 1986;17:2383-5.
Klar E, Rattner D, Compton C, et al. Adverse effect of therapeutic vasoconstrictors in experimental acute pancreatitis. Ann Surg 1991;214;168-74.
Steinberg W, Tenner S. Acute pancreatitis. New Engl J Med 1994;330:1198-210.
Davis TV, Keeffe EB. Acute pancreatitis associated with acute hepatitis A. Am J Gastroenterol 1992;8:1648-50.
Bonacini M. Pancreatic involvement in human immuno-deficiency virus infection. J Clin Gastroenterol 1991;13:58-64.
Khuroo MS, Zargar SA, Yattoo GN, et al. Ascaris-induced acute pancreatitis. Br J Surg 1992;79:1335
Bouteloup C, Michel P, Desechalliers IP, et al. Pancreatite aigue recidivanteo Taenia saginatia Gastroenterol Clin Biol 1992, 16:818-20.
Poisindex Toxicologic Managements. Micromedex, Inc. 1974-1997.
Meier PB.Preventing ERCP-induced pancreatis. Am J
Gastroenterol 1992;87:1536-9.
Moulis H, Vender RJ. Pancreatitis affer endoscopic cholangiography wibout pancreatiography. Am J Gastroenterol 1992;87:1888-9.
Delcenserie R, Grange ID, Laugier R, et al. Definition et criteres d'imputabilite des atteintes pancreatiques aignes med icamenteuses. Gastrocnterol Clin Biol 1992;16:761-3
Mallory A, Kcm F. Drug-induced Pancreatitis Bailiere's Clin Gastroenterol 1988:2:293-307.